🇺🇸 FDA
Patent

US 7495018

Substituted 1,3-thiazole compounds, their production and use

granted A61PA61P11/00A61P17/00

Quick answer

US patent 7495018 (Substituted 1,3-thiazole compounds, their production and use) held by Takeda Pharmaceutical Company Limited expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P11/00, A61P17/00, A61P19/00, A61P25/00